AwesomeCapital
Search This Blog
Monday, March 2, 2020
Heron Therapeutics EPS misses by $0.09, beats on revenue
Heron Therapeutics (NASDAQ:
HRTX
): Q4 GAAP EPS of -$0.65
misses by $0.09
.
Revenue of $35.1M (+21.7% Y/Y)
beats by $3.29M
.
Press Release
https://seekingalpha.com/news/3547353-heron-therapeutics-eps-misses-0_09-beats-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.